These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25843247)
1. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247 [TBL] [Abstract][Full Text] [Related]
2. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy. Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085 [TBL] [Abstract][Full Text] [Related]
3. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter]. Pan YX; Wu Y; Niu ZP; Jiang YW Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687 [TBL] [Abstract][Full Text] [Related]
4. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report. Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042 [TBL] [Abstract][Full Text] [Related]
5. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386 [TBL] [Abstract][Full Text] [Related]
6. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease. Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813 [TBL] [Abstract][Full Text] [Related]
7. Vanishing white matter: deregulated integrated stress response as therapy target. Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619 [TBL] [Abstract][Full Text] [Related]
8. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758 [TBL] [Abstract][Full Text] [Related]
9. Leukoencephalopathy with vanishing white matter: a review. Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246 [TBL] [Abstract][Full Text] [Related]
10. Vanishing white matter. van der Knaap MS; Bugiani M; Abbink TEM Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396 [TBL] [Abstract][Full Text] [Related]
11. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model. Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808 [TBL] [Abstract][Full Text] [Related]
13. Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. Zhang H; Dai L; Chen N; Zang L; Leng X; Du L; Wang J; Jiang Y; Zhang F; Wu X; Wu Y PLoS One; 2015; 10(3):e0118001. PubMed ID: 25761052 [TBL] [Abstract][Full Text] [Related]
14. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease. Wortham NC; Proud CG BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592 [TBL] [Abstract][Full Text] [Related]
15. Adult-onset leukoencephalopathy with vanishing white matter with compound heterozygous EIF2B3 gene variants. Gui M; He M; Qin L BMC Neurol; 2024 Jun; 24(1):201. PubMed ID: 38872124 [TBL] [Abstract][Full Text] [Related]
16. Vanishing white matter disease with different faces. Güngör G; Güngör O; Çakmaklı S; Maraş Genç H; İnce H; Yeşil G; Dilber C; Aydın K Childs Nerv Syst; 2020 Feb; 36(2):353-361. PubMed ID: 31385086 [TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients. Ren Y; Yu X; Chen B; Tang H; Niu S; Wang X; Pan H; Zhang Z Neurol Sci; 2022 Aug; 43(8):4961-4977. PubMed ID: 35389136 [TBL] [Abstract][Full Text] [Related]
18. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases. Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698 [TBL] [Abstract][Full Text] [Related]
19. Ovarioleukodystrophy due to EIF2B5 mutations. Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498 [TBL] [Abstract][Full Text] [Related]